[1] Cerio R, Dirschka T, Dréno B, et al. Actinic keratosis, a chronic, progressive disease: understanding clinical gaps to optimise patient management[J]. Acta DermVenereol, 2017, 97(8): 997-998.
[2] Koch E A , Petzold A, Wessely A,et al.A Critical appraisal of evidence- and consensus-based guidelines for Actinic Keratosis[J].Curr Oncol,2021,28(1):950-960.
[3] Marco M. Photodynamic therapy activated by intense pulsed light in the treatment of actinic keratosis[J].G Ital Dermatol Venereol,2020,155(4):470-476.
[4] Fargnoli M C, Altomare G, Benati E, et al. Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics [J]. Eur J Dermatol, 2017, 27 (6): 599-608.
[5] Fleming P, Zhou S, Bobotsis R,et al.Comparison of the treatment guidelines for acti-nic keratosis: a critical appraisal and review[J]. J Cutan Med Surg,2017,21(5):408-417.
[6] 赵 辨. 中国临床皮肤病学[M].2版.南京:江苏科学技术出版社,2017:728.
[7] Bolognia J L, Jorizzo J L, Rapini RP,et al. 皮肤病学[M]. 朱学骏,王宝玺,孙建方,等,译. 北京:北京大学医学出版社,2011:2014-2021.
[8] 高 丽,刘 宇,黄 敏,等.光线性角化病385例临床与组织病理特点回顾性分析[J].临床皮肤科杂志,2016,45(7):496-499.
[9] 陈文静,伊力努尔,梁俊琴,等.5-氨基酮戊酸光动力疗法治疗皮肤癌前病变及浅表皮肤肿瘤的疗效观察[J].中国医师杂志,2017,19(2):273-274.
[10] Han Y, Ying H,Zhang X,et al.Retrospective study of photodynamic therapy for pulsed dyelaser-resistant port-wine stains[J].J Dermatol,2020,47(4):348-355.
[11] 凌绍枝,屈亚威,刘海峰.光动力治疗及其临床应用研究[J].武警医学,2017,28(2):203-207.
[12] 韩佳彤,王佩茹,王秀丽.5-氨基酮戊酸光动力疗法治疗鼻部日光性角化病疗效评价[J].中国眼耳鼻喉科杂志,2018,18(3):175-177.
[13] Wen X,Li Y,Hamblin M R.Photodynamic therapy in dermatology beyond non-melanoma cancer: an update[J]. Photodiagn Photodyn,2017,19: 140-152.